TRIB 0.93 (-7%)
US8964383066Medical Diagnostics & ResearchDiagnostics & Research

Trinity Biotech (TRIB) Stock Highlights

0.93 | -7%
2024-12-07 06:56:31
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Ireland of which it derives a majority of its revenues from the Americas segment.

Statistics

Range Today
0.86 1.01
Volume Today 206.4K
Range 1 Year
1 3.55
Volume 1 Year 99.47M
Range 3 Year
1 9.95
Volume 3 Year 112.84M
Range 10 Year
1 101.2
Volume 10 Year 180.84M

Highlights

Market Capitalization 15.24M (micro)
Floating Shares 95.9M
Current Price 0.93
Price To Earnings -0.63
Price To Revenue 6.7
Earnings Per Share -2.57
Payout Ratio 0%

Performance

Latest -7%
1 Month -46.24%
3 Months -44.64%
6 Months -54.85%
1 Year -65.56%
3 Years -89.06%
5 Years -81.02%
10 Years -98.9%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.